Newsroom
  • June 14 , 2021

    Toward the first drug to treat a rare, lethal liver cancer

    Sanford M. Simon and his group understood that patients dying of fibrolamellar could not afford to wait.The team ultimately discovered a few classes of therapeutics that destroy fibrolamellar tumor cells growing in mice. Their findings are published in Cancer Discovery.
    Read more
  • June 14 , 2021

    Study finds dosing strategy may affect immunotherapy outcomes

    Overweight cancer patients receiving immunotherapy treatments live more than twice as long as lighter patients, but only when dosing is weight-based, according to a study by cancer researchers at UT Southwestern Medical Center.
    Read more
  • June 14 , 2021

    An omega-3 that's poison for tumors

    ​So-called "good fatty acids" are essential for human health. Among the Omega-3 fatty acids, DHA, or docosahexaenoic acid, is crucial to brain function, vision and the regulation of inflammatory phenomena.
    Read more
  • June 10 , 2021

    'Bad fat' suppresses killer T cells from attacking cancer

    In order for cancer to grow and spread, it has to evade detection by our immune cells, particularly specialized "killer" T cells. Salk researchers led by Professor Susan Kaech have found that the environment inside tumors (the tumor microenvironment) contains an abundance of oxidized fat molecules, which, when ingested by the killer T cells, suppresses their
    Read more
  • June 10 , 2021

    Study shows how certain macrophages dampen anti-tumor immunity

    A Ludwig Cancer Research study adds to growing evidence that immune cells known as macrophages inhabiting the body cavities that house our vital organs can aid tumor growth by distracting the immune system's cancer-killing CD8+ T cells.
    Read more
  • June 10 , 2021

    A new technique for correcting disease-causing mutations

    Gene editing, or purposefully changing a gene's DNA sequence, is a powerful tool for studying how mutations cause disease, and for making changes in an individual's DNA for therapeutic purposes. A novel method of gene editing that can be used for both purposes has now been developed by a team led by Guoping Feng, the James W. (1963) and Patricia T. Poitras P
    Read more
  • June 7 , 2021

    Researchers develop method for rapid, accurate detection of viruses

    Read more
  • June 1 , 2021

    'Electronic nose' accurately sniffs out hard-to-detect cancers

    An odor-based test that sniffs out vapors emanating from blood samples was able to distinguish between benign and pancreatic and ovarian cancer cells with up to 95 percent accuracy, according to a new study from researchers at the University of Pennsylvania and Penn's Perelman School of Medicine.
    Read more
  • May 31 , 2021

    Exploring CAR T-cell therapy to treat breast cancer

    Peter Mac researchers are developing a potential new way to make CAR T-cell therapy more effective against breast cancer and other solid cancers.
    Read more
  • May 26 , 2021

    New biochip technology for pharma research

    In pharmaceutical research, small tissue spheres are used as mini-organ models for reproducible tests. TU Wien has found a way to develop a reliable standard for these tissue samples.
    Read more
  • May 20 , 2021

    New biosensor developed to aid early diagnosis of breast cancer

    A team of Spanish researchers have developed, at the laboratory level, a prototype of a new biosensor to help detect breast cancer in its earliest stages. One of the team coordinators has been Ramón Martínez Máñez, a professor at the Universitat Politècnica de València (UPV) and the scientific director of the Networking Biomedical Research Centre in Bioengin
    Read more
  • January 20 , 2021

    Chinese Scientists Develop Gene Therapy that Could Delay Aging

    Scientists in Beijing have developed a new gene therapy which can reverse some of the effects of aging in mice and extend their lifespans, findings which may one day contribute to similar treatment for humans.
    Read more
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read More
If you would like to get in touch with us, please click here. Contact us